Robert G. Shawah - 05 Feb 2025 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
Chief Financial Officer
Signature
/s/ Jeffrey Cohan, Power of Attorney For: Robert G. Shawah
Issuer symbol
ACXP
Transactions as of
05 Feb 2025
Transactions value $
$0
Form type
4
Filing time
06 Feb 2025, 17:47:58 UTC
Previous filing
03 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Stock Option Award $0 +145,500 $0 145,500 05 Feb 2025 Common Stock 145,500 $0.7982 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 5, 2025, the Reporting Person was granted stock options to purchase 145,500 shares of the Issuer's common stock. These options vest immediately.